Skip to main content

MoneyWorks4Me

Transgene Biotek informs about quarterly statement of investor complaint

13 Jan 2016 Evaluate

Transgene Biotek has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 43.70
Prime Focus 274.60
Indegene 665.85
Syngene Internatl. 447.65
Knowledge RealtyTrt. 111.28
View more..